Back to Journals » Drug, Healthcare and Patient Safety » Volume 16 » default
Drug, Healthcare and Patient Safety
ISSN: 1179-1365
- View all (283)
- Volume 16, 2024 (5)
- Volume 15, 2023 (16)
- Volume 14, 2022 (19)
- Volume 13, 2021 (25)
- Volume 12, 2020 (35)
- Volume 11, 2019 (15)
- Volume 10, 2018 (12)
- Volume 9, 2017 (11)
- Volume 8, 2016 (13)
- Volume 7, 2015 (20)
- Volume 6, 2014 (22)
- Volume 5, 2013 (23)
- Volume 4, 2012 (18)
- Volume 3, 2011 (15)
- Volume 2, 2010 (25)
- Volume 1, 2009 (9)
Archive: Volume 16, 2024
Rapid Onset and Recovery Linezolid-Induced Thrombocytopenia: A Large-Sample, Single-Center Retrospective Cohort Study
AL Qamariat Z, Aljaffar AA, Alabdulaal ZS, Alnezir F, Al-Zawad WM, Alqattan M, Almahdi A
Drug, Healthcare and Patient Safety 2024, 16:43-49
Published Date: 21 May 2024
Response to Osilodrostat Therapy in Adrenal Cushing’s Syndrome
Stasiak M, Witek P, Adamska-Fita E, Lewiński A
Drug, Healthcare and Patient Safety 2024, 16:35-42
Published Date: 8 April 2024
Obstructive Fibrinous Tracheal Pseudomembrane Following Repeated Intratracheal Interventions
Tang W, Zhou W, Zheng X
Drug, Healthcare and Patient Safety 2024, 16:29-33
Published Date: 6 March 2024
Evaluation of Seven Different Brands of Metformin Hydrochloride Tablets Available in the Market in Gondar City, Ethiopia
Flatie Alemu A, Tegegne AA, Getaw NS
Drug, Healthcare and Patient Safety 2024, 16:19-28
Published Date: 1 February 2024
Validity of Routine Health Data To Identify Safety Outcomes of Interest For Covid-19 Vaccines and Therapeutics in the Context of the Emerging Pandemic: A Comprehensive Literature Review
Andresen K, Hinojosa-Campos M, Podmore B, Drysdale M, Qizilbash N, Cunnington M
Drug, Healthcare and Patient Safety 2024, 16:1-17
Published Date: 3 January 2024